Skip to main content

The Wistar Institute

|

A Closer Look into Our Scientific Enterprise

Dr. Luis Montaner, Wistar’s Associate Director for Shared Resources, and Mark Drinker, Wistar’s Associate Director for Administration of the Ellen and Ronald Caplan Cancer Center, chat about core facilities that support the innovations of our Wist…
|

Zooming in on Microscopes at Wistar

From historic machinery in one of our own investigator’s personal collection to the modern technology transforming Wistar research today, microscopes have helped Wistar scientists and researchers around the world pursue innovative investigations. …
|

Highlighting Vaccine Research at The Wistar Institute Through the Penn-CHOP-Wistar Vaccine Symposium

From HIV to COVID-19, Wistar scientists are at the forefront of vaccine development. Read our recap of the recent Vaccine Symposium and the impactful research in progress at the Institute. This past Monday, The Wistar Institute, University of Penn…
|

Distinguished Lectures in Cancer Research Series: The Eukaryotic RNA-protein Interaction Code: Binding, Interfaces, and Evolution

Scientific Seminar Tuesday, Apr. 26, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of the Ellen and Ronald Caplan Cancer Center and features national and international leaders in b…
|

Distinguished Lectures in Cancer Research Series: Understanding the Role of Metabolism in Cancer

Scientific Seminar Tuesday, May 24, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of the Ellen and Ronald Caplan Cancer Center and features national and international leaders in ba…
|

The Wistar Institute Cancer Center to be Renamed with $10 Million Gift from Caplan Family to Advance Cancer Research

PHILADELPHIA — (March 8, 2022) — The Wistar Institute announces that Ronald Caplan, founder and president of PMC Property Group, Inc., and his wife Ellen have donated $10 million to Wistar’s prestigious National Cancer Institute (NCI)-designated C…
|

Wistar’s Education & Training Team Visits Vaux High School to Connect on Life Science Careers

Wistar’s Drs. Kristy Shuda McGuire, dean of biomedical studies, and David Zuzga, associate dean of biomedical studies, spent an evening with students at Vaux Big Picture High School in north central Philadelphia to discuss all the STEM job opportu…
|

Women & Science: Pain, Itch, and Inflammation

Dr. Diana Bautista has dedicated her professional life to the science of literal human connection: our sense of touch. A Howard Hughes Medical Investigator and professor of cell and developmental biology at University of California, Berkeley, Baut…
|

Wistar Scientists Identify Therapeutic Target for Metastatic Cancers

Damaged “ghost” mitochondria are found to drive tumor progression. Metastasis, or the spread of cancer from one place in the body to another, is responsible for more than 90% of all cancer deaths. Therefore, determining how and why this happens is…
|

Wistar Study Opens the Door to Faster, Cheaper HIV Vaccine Research

For the first time, scientists have developed an DNA-encoded immunogen that produces Tier-2 antibodies—the kind that matter for combatting HIV Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. P…